Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, FibroBiologics Inc (NASDAQ: FBLG) closed at $0.45 down -7.32% from its previous closing price of $0.49. In other words, the price has decreased by -$7.32 from its previous closing price. On the day, 1.51 million shares were traded. FBLG stock price reached its highest trading level at $0.4993 during the session, while it also had its lowest trading level at $0.4401.
Ratios:
For a deeper understanding of FibroBiologics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 12.53 whereas as Long-Term Debt/Eq ratio is at 2.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on December 12, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.
On September 24, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $12.Maxim Group initiated its Buy rating on September 24, 2024, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 27 ’25 when Khoja Hamid bought 20,000 shares for $0.84 per share. The transaction valued at 16,800 led to the insider holds 31,250 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBLG now has a Market Capitalization of 18921326 and an Enterprise Value of 20852326.
Stock Price History:
The Beta on a monthly basis for FBLG is -0.66, which has changed by -0.8325926 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, FBLG has reached a high of $3.89, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is -19.81%, while the 200-Day Moving Average is calculated to be -54.22%.
Shares Statistics:
For the past three months, FBLG has traded an average of 607.77K shares per day and 1357770 over the past ten days. A total of 40.86M shares are outstanding, with a floating share count of 30.01M. Insiders hold about 28.35% of the company’s shares, while institutions hold 12.27% stake in the company. Shares short for FBLG as of 1759190400 were 965853 with a Short Ratio of 1.59, compared to 1756425600 on 917549. Therefore, it implies a Short% of Shares Outstanding of 965853 and a Short% of Float of 2.69.
Earnings Estimates
The performance of FibroBiologics Inc (FBLG) in the stock market is under the watchful eye of 2 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.45 and -$0.48 for the fiscal current year, implying an average EPS of -$0.47. EPS for the following year is -$0.52, with 2.0 analysts recommending between -$0.46 and -$0.59.
